Increased outlook for full-year 2020

14 December, 2020

Marcy l'Étoile, December 14,  2020 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its adjusted outlook for full-year 2020.


  • Full-year 2020 net sales are now expected to be around 18% at constant exchange rates and scope of consolidation and contributive operating income before non-recurring items  about €600 million. 
  • As a reminder, this 2020 exceptional performance is not projectable beyond 2020.